Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hypogonadism × Genitourinary × Clear all

Phase

Status

Completed 6 Suspended 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 211 Urinary Bladder Neoplasms 56 Carcinoma, Renal Cell 50 Neoplasms 29 Non-Muscle Invasive Bladder Neoplasms 26 Kidney Neoplasms 26 Carcinoma, Transitional Cell 16 Breast Neoplasms 16 Melanoma 13 Adenocarcinoma 13 Neoplasm Metastasis 10 Lung Neoplasms 10 Stomach Neoplasms 7 Endometrial Neoplasms 7 Disease 7 Colorectal Neoplasms 7 Uterine Cervical Neoplasms 6 Testicular Neoplasms 6 Pancreatic Neoplasms 6 Head and Neck Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6 Carcinoma, Non-Small-Cell Lung 6 Urologic Neoplasms 5 Recurrence 5 Penile Neoplasms 5 Ovarian Neoplasms 5 Liver Neoplasms 5 Acute Kidney Injury 5 Urinary Incontinence 4 Triple Negative Breast Neoplasms 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07535905 2026-04-17

REVIVE

University Health Network, Toronto

Phase 2 Not yet recruiting

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡